戻る Agenda
Session 7C: Review Standards for Ad Boards and Consultant Meetings
Session Chair(s)
Mark Gaydos
Global Head, Advertising & Promotion, Global Regulatory Affairs
Sanofi, United States
Advisory boards and consulting arrangements are common business practices that permit companies to obtain expert advice on matters ranging from clinical development plans, product positioning and promotional messaging, as well as postmarketing studies and other life cycle management activities. While representing standard business practice, such relationships with external health care professionals are fraught with risks that must be acknowledged and accounted for in order to protect companies and individuals from external allegations of illegality. We will explore the legal and regulatory risk areas associated with ad boards and consulting arrangements, from both internal and external perspectives, and discuss steps companies can take to ensure their validity and minimize associated risks.
Speaker(s)
Advisor and Consultant Arrangements: Avoiding Regulatory Peril
Mark Gaydos
Sanofi, United States
Global Head, Advertising & Promotion, Global Regulatory Affairs
Meeting Legal and Regulatory Requirements While Meeting With Your Consultants: Learning From Enforcement Trends
Linda Pissott Reig, JD
Buchanan Ingersoll & Rooney PC, United States
Shareholder
Legal Considerations for Advisory Boards
Felecia Ettenberg, JD
Bristol-Myers Squibb, United States
Executive Director, Promotion Integrity